U.S. Software Stock News

Ferguson Enterprises stock was riding a solid 30 day gain coming into this earnings print. The shares then dropped about 4.7% today. That is a sharp reset for a distributor that many investors view as a steady compounder in plumbing, HVAC and infrastructure. The headline is simple: earnings held up better than the price reaction suggests. Revenue reached about US$8.8b in the quarter and diluted earnings per share came in around US$3.39. Trailing 12 month earnings of just over US$10 per share...

Kinder Morgan recently joined Phillips 66 and HF Sinclair in announcing a joint venture to develop the Western Gateway Pipeline system, expanding its role in transporting energy products across key North American corridors. This collaboration highlights how Kinder Morgan can use its extensive infrastructure and strong free cash flow to pursue capital projects alongside industry peers. We’ll now examine how Kinder Morgan’s Western Gateway Pipeline joint venture could influence its investment...

UnitedHealth Group just delivered a punchy earnings headline while the stock quietly slipped. Shares closed at US$402.20, down about 1.6% on the day and modestly weaker over the past month, even as quarterly adjusted earnings per share landed at US$6.38 and operating earnings rose sharply compared with a year ago. The market looks more cautious than the numbers alone might suggest. Investors seem to be discounting the earnings strength and raised full year guidance, and instead leaning into...

FTAI Infrastructure entered this earnings season with a troubled reputation and low expectations, yet the stock nudged 1.6% higher to about US$4.37 by the close. The market is trying to price in a potential turnaround story while the income statement still shows heavy red ink. Q2 revenue came in at about US$186.8 million, but the company reported a net loss of roughly US$166.5 million and basic earnings per share of a loss of US$1.41. The real headline is not the modest price increase...

Green Dot stock barely flinched after earnings, ticking up about 1% to US$13.41, yet the numbers point to a far more dramatic story than the share price suggests. A consumer finance company that has been wrestling with rising losses just put up one of its cleanest quarterly profit lines in recent memory, with Q1 2026 basic earnings per share at US$0.96 on revenue of US$654.7m. For a business that has reported trailing twelve month net income losses, this kind of earnings power instantly...

Caledonia Mining stock closed up 1.1% at US$22.97, a calm move for what is a punchy set of numbers. The market treated today as a small win. The income statement looks more like a statement of intent. The headline is earnings power. Second quarter basic earnings per share landed at US$1.36 on revenue of about US$72.0m, with net income of US$23.8m. That keeps the trailing twelve month profit picture firm and leaves Caledonia Mining trading on a single digit P/E multiple. Short term traders saw...

Alpha Tau Medical earnings put recent clinical progress in context Alpha Tau Medical (NasdaqCM:DRTS) has paired a series of high profile clinical and partnership milestones with fresh half year results that show a wider net loss and higher loss per share. The company reported a net loss of US$68.75 million for the half year to June 30, 2026, compared with a loss of US$18.81 million a year earlier. Basic and diluted loss per share from continuing operations were both US$0.76, compared with...

Why ACADIA Pharmaceuticals Stock Is Back in Focus After Guidance Update ACADIA Pharmaceuticals (ACAD) put its stock firmly on investors’ radar after raising 2026 earnings guidance and reporting second quarter results that showed higher revenue and net income compared with a year earlier. The company now expects 2026 revenue between US$1.24b and US$1.30b, with NUPLAZID projected at US$760 million to US$790 million and DAYBUE at US$480 million to US$510 million. These updated figures illustrate...

Central banks are talking tougher on inflation, growth forecasts are being cut, and energy markets remain volatile, which puts the spotlight squarely on large energy stocks exposed to these pressures. For investors, this mix of risk and potential resilience can reshape how you think about where to put new money or what to hold. This article breaks down 3 energy stocks affected by the recent news and explains why each may warrant a closer look now. The three stocks covered below are just a...

Bio-Rad Laboratories (BIO) has moved into focus after its second quarter 2026 earnings and fresh guidance, which combined a slight overall revenue decline with firmer contributions from several international markets. See our latest analysis for Bio-Rad Laboratories. The recent guidance and international revenue patterns arrived alongside a sharp shift in sentiment around Bio-Rad Laboratories, with a 46.30% 90 day share price return and a 29.66% 1 year total shareholder return contrasting with...

In early August 2026, The Timken Company reported second-quarter results showing sales rising to US$1,260.9 million from US$1,173.4 million a year earlier, while net income fell to US$28.9 million from US$78.5 million, alongside confirming a US$0.36 quarterly dividend and completing a US$47.97 million share repurchase program. At the same time, Timken raised its 2026 earnings and revenue outlook and reworked its senior leadership team to support its Elevate to Outperform plan, signaling a...

In early August 2026, Curio announced a Memorandum of Understanding with NuScale Power and Framatome to assess an integrated, closed-loop nuclear fuel solution using Curio’s NuCycle recycling technology to support domestic and international nuclear fuel supply chains. This collaboration highlights growing industry interest in pairing NuScale’s small modular reactor platform with advanced fuel-cycle technologies that aim to reduce waste volumes and strengthen long-term nuclear energy...

Ichor Holdings, Ltd. reported second-quarter 2026 results showing sales of US$294.78 million and net income of US$0.998 million, a shift from a loss a year earlier, and issued third-quarter revenue guidance of US$315 million to US$345 million with expected GAAP diluted EPS between US$0.25 and US$0.35. These results indicate improved profitability and higher sales compared with the prior year period, while the company’s forward guidance offers investors clearer expectations around revenue and...

With investors glued to upcoming US inflation data, oil price swings and firm Treasury yields, high dividend yield stocks are drawing fresh attention from anyone looking for steadier income while markets debate the Federal Reserve’s next move in September. This article looks at how those macro forces link back to company fundamentals and payout strength. You will see three stocks from the screener that appear positively exposed to the current backdrop. The three stocks highlighted below are...

Apnimed, Inc (NasdaqGS:APMD) has been added to the NASDAQ Composite Index following its recent IPO. The addition comes soon after Apnimed filed a shelf registration statement, signaling further corporate funding flexibility. Index inclusion typically draws attention from index-tracking funds and can affect trading volumes and liquidity. This kind of index move, combined with fresh IPO activity, points to a wider group of stocks that may be worth a closer look through 51 high quality...

FIFA’s leadership turmoil and talk of boycotts has put the business of global football under an uncomfortable spotlight, from billion dollar media rights to sponsorships tied to future World Cups. That disruption risk also creates an opening for investors watching sports media and broadcasting stocks exposed to this news. This article breaks down how three stocks from our screener are positioned, so you can judge whether the story fits your portfolio. The stocks covered below are just a...

Keel Infrastructure stock has delivered a very strong 176.4% return over the past year, yet the company only passes 1 of 6 valuation checks, which raises questions about how much of that performance is supported by fundamentals after recent setbacks. The 176.4% one year gain stands in sharp contrast to the recent pullback. This may signal that expectations built up faster than the market is now comfortable with. The shift away from U.S. Bitcoin mining toward AI and high performance computing...

Ingles Markets, Incorporated reported past third-quarter 2026 results with sales of US$1,368.32 million and net income of US$25.9 million, alongside higher nine‑month sales of US$4,049.16 million and net income of US$78.3 million versus the prior year. While quarterly earnings per share were almost unchanged, the nine‑month EPS from continuing operations rose to US$4.12, highlighting stronger year‑to‑date profitability despite a board resignation for personal reasons. We’ll now examine how...

GEO Group has delivered a very strong 317.1% return over the last three years, yet the shares now screen as overvalued on market multiples even while the broader valuation checks lean supportive. That mix of a big past gain with a richer pricing signal is what investors are trying to make sense of today. Over the last three years GEO Group has returned 317.1%, which puts a lot of past gains on the table and raises the bar for any new buyers at current levels. New federal immigration...

Penumbra, Inc. recently initiated a voluntary Class II recall of its Penumbra System RED 68 Reperfusion Catheter across multiple US states and international markets due to manufacturing issues that may cause catheter fractures, following firm notifications sent out in early June 2026. This recall comes shortly after Penumbra reported higher quarterly sales of US$390.05 million but lower net income of US$34.81 million and reduced earnings per share versus a year earlier, highlighting growing...

Sionna Therapeutics recently reported that its Phase 2a PreciSION CF trial of NBD1 stabilizer SION-719 added to Trikafta did not improve sweat chloride levels, leading the company to discontinue SION-719 as an add-on therapy and to reassess its clinical plans. At the same time, early data from SION-451 combination studies and a cash balance of about US$268.3 million give Sionna room to reconsider how it pursues cystic fibrosis therapies while preserving capital. We’ll now examine how...

As AI moves from buzzword to core toolkit for tracking inflation, jobs and growth in real time, investors are no longer limited to slow, revision prone government reports. That shift is creating a data gap between companies that power these new insights and everyone else, and missing it could mean missing the next big story. This article walks through three AI and data analytics stocks exposed to that news and explains why they stand out right now. The three stocks highlighted below are just...

Upbound Group (UPBD) recently reported second quarter 2026 results and updated its outlook, which appears to be the key driver for the latest stock move as investors reassess earnings quality and guidance. See our latest analysis for Upbound Group. The latest move in Upbound Group's share price, which is down 3.08% over the last day at $19.22 and down 9.17% over the past month, comes after second quarter earnings, refined revenue guidance, and confirmation that the buyback program has now...

Enpro Inc. reported its second-quarter 2026 results, with sales rising to US$338.8 million and net income reaching US$27.1 million, while also affirming a quarterly dividend of US$0.32 per share payable in September 2026. The company also raised its 2026 revenue growth outlook to a range of 14% to 16%, indicating increased confidence relative to its prior expectations. Now we’ll assess how Enpro’s higher 2026 revenue growth guidance may reshape the existing investment narrative built on...